Drawing for QBCLINIC

USPTO serial 98722636

QBCLINIC

Reviewed by CopyMark Law Group

Reg. 8082453Status 700Registered
Filing date
Status date
Registration date
Dec 30, 2025
Examiner
BROWNING, KATHRYN ELISABETH
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with QBCLINIC?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Maurine Knutsson

Maurine Knutsson Knutsson IP ABNelinsgatan 14Norrkoping, 60345SWEDEN

Goods and services

ClassDescriptionStatusFirst use
009data processing equipment; downloadable and recorded computer programs for medical diagnosis of behavior disorders, neurodevelopmental disorders, Attention Deficit Disorder (ADD), and Attention Deficit Hyperactivity Disorder (ADHD) and the collection of test results used in determining the existence, type, and extent of behavior disorders, neurodevelopmental disorders, Attention Deficit Disorder (ADD), and Attention Deficit Hyperactivity Disorder (ADHD) for patient assessment; recorded computer programs in the field of medical diagnostics and for the purpose of collection of test results for patient assessment; downloadable computer programs in the field of medical diagnostics and for the purpose of collection of test results for patient assessment; downloadable computer programs, including for medical diagnostics and the collection of test results for patient assessment, namely, Software as a Medical Device (SaMD), downloadable, for diagnosing and treating behavioral disorders, neurodevelopmental disorders, Attention Deficit Disorder (ADD), and Attention Deficit Hyperactivity Disorder (ADHD)ACTIVE—
035business administration relating to medical diagnostics; compiling statistical business data and patient assessment; business administration in the field of medical diagnostics ; business administration in the field of medical diagnosis of behavior disorders, neurodevelopmental disorders, Attention Deficit Disorder (ADD), and Attention Deficit Hyperactivity Disorder (ADHD)ACTIVE—
042development of test methods for use in the diagnosing, monitoring, examining, and treating behavior disorders, neurodevelopmental disorders, Attention Deficit Disorder (ADD), and Attention Deficit Hyperactivity Disorder (ADHD); Development and establishment of testing specifications and procedures in the field of behavior disorders, neurodevelopmental disorders, Attention Deficit Disorder (ADD), and Attention Deficit Hyperactivity Disorder (ADHD); scientific and technological services, namely, medical and scientific research in the field of behavioral disorders, neurodevelopmental disorders, Attention Deficit Disorder (ADD), and Attention Deficit Hyperactivity Disorder (ADHD); technological services, design and development of computer software for use in the diagnosing, monitoring, examining, and treating behavioral disorders, neurodevelopmental disorders, Attention Deficit Disorder (ADD), and Attention Deficit Hyperactivity Disorder (ADHD); analytical services relating to computer programs and patient data, namely, analysis of patient data on computer systems relating to diagnosing, monitoring, examining, and treating behavioral disorders, neurodevelopmental disorders, Attention Deficit Disorder (ADD), and Attention Deficit Hyperactivity Disorder (ADHD); computer systems analysis, namely, analysis of patient data on computer systems; medical services being medical research; Scientific research in the nature of conducting clinical trials for others; providing a website featuring information in the field of investigational medical diagnostics related to behavioral disorders, neurodevelopmental disorders, Attention Deficit Disorder (ADD), and Attention Deficit Hyperactivity Disorder (ADHD); scientific and technological services, namely, scientific research, analysis and testing in the field of behavioral and neurological disorders; computer system analysis; medical research in the field of behavioral and neurological disorders; medical and scientific research, namely, conducting clinical trials for others; compiling data for research purposes in the field of medical science and medical consultancy; consulting services in the field of medical research; consulting services in the fields of medical research; providing temporary use of non-downloadable computer programs for medical diagnosis of behavior disorders, neurodevelopmental disorders, Attention Deficit Disorder (ADD), and Attention Deficit Hyperactivity Disorder (ADHD) and the collection of test results used in determining the existence, type, and extent of behavior disorders, neurodevelopmental disorders, Attention Deficit Disorder (ADD), and Attention Deficit Hyperactivity Disorder (ADHD) for patient assessment; providing temporary use of non-downloadable computer programs, including for medical diagnostics and the collection of test results for patient assessment, namely, Software as a Service (SaaS) services featuring software for diagnosing and treating behavioral disorders, neurodevelopmental disorders, Attention Deficit Disorder (ADD), and Attention Deficit Hyperactivity Disorder (ADHD); technological services, namely, Software as a Service (SaaS) services featuring software for diagnosing and treating behavioral disorders, neurodevelopmental disorders, Attention Deficit Disorder (ADD), and Attention Deficit Hyperactivity Disorder (ADHD); technological services, namely, Software as a Service (SAAS) services featuring software for collection of test results for patient assessment in the field of medical diagnostics; technological services, namely, Software as a service (SAAS) services featuring software for use in the diagnosing, monitoring, examining, and treating behavior disorders, neurodevelopmental disorders, Attention Deficit Disorder (ADD), and Attention Deficit Hyperactivity Disorder (ADHD); technological services, namely, Software as a service (SAAS) services featuring software for accessing, managing, importing, exporting, securing, and acquiring patient data relating to diagnosing, monitoring, examining, and treating behavioral disorders, neurodevelopmental disorders, Attention Deficit Disorder (ADD), and Attention Deficit Hyperactivity Disorder (ADHD); technological services, namely, Platform as a service (PAAS) services featuring software platforms for diagnosing and treating behavioral disorders, neurodevelopmental disorders, Attention Deficit Disorder (ADD), and Attention Deficit Hyperactivity Disorder (ADHD); technological services, namely, Platform as a service (PAAS) services featuring software platforms for collection of test results for patient assessment in the field of medical diagnostics; technological services, namely, Platform as a service (PAAS) services featuring software platforms for use in the diagnosing, monitoring, examining, and treating behavior disorders, neurodevelopmental disorders, Attention Deficit Disorder (ADD), and Attention Deficit Hyperactivity Disorder (ADHD); technological services, namely, Platform as a service (PAAS) services featuring software platforms for accessing, managing, importing, exporting, securing, and acquiring patient data relating to diagnosing, monitoring, examining, and treating behavioral disorders, neurodevelopmental disorders, Attention Deficit Disorder (ADD), and Attention Deficit Hyperactivity Disorder (ADHD); computer-supported services within medical diagnostics and patients assessment, namely, proving online non-downloadable computer software platforms for diagnosing and assessing patients in the field of behavioral disorders, neurodevelopmental disorders, Attention Deficit Disorder (ADD), and Attention Deficit Hyperactivity Disorder (ADHD); computer-supported services within medical diagnostics and patients assessment, namely, Software as a Service (SaaS) services featuring software for diagnosing and assessing behavioral disorders, neurodevelopmental disorders, Attention Deficit Disorder (ADD), and Attention Deficit Hyperactivity Disorder (ADHD); computer-supported services within medical diagnostics and patients assessment, namely, Software as a Service (SAAS) services featuring software for collection of test results for patient assessment in the field of medical diagnostics; medical consultations provided online, namely, providing online non-downloadable computer software platforms for providing online medical consultations in the field of behavioral disorders, neurodevelopmental disorders, Attention Deficit Disorder (ADD), and Attention Deficit Hyperactivity Disorder (ADHD)ACTIVE—
044consultancy services relating to medicine and healthcare; computer-supported services within medical diagnostics and patients assessment, namely, medical assistance services in the nature of medical information provided to medical professionals from remote locations via the Internet and global computer networks through the use of archived medical images, documents, and data and a data storage and retrieval system, all relating to medical diagnostics and patient assessment; medical consultations provided online via chat, e-mail, telephone service over the internet, and video conference; consulting services in the fields of clinical testing; medical services being medical testing services; medical services being medical testing for diagnostic or treatment purposes; medical services being clinical testing in the field of behavioral disorders, neurodevelopmental disorders, Attention Deficit Disorder (ADD), and Attention Deficit Hyperactivity Disorder (ADHD)ACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Dec 30, 2025NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Dec 30, 2025R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Nov 11, 2025NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Nov 11, 2025PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Nov 5, 2025NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Oct 9, 2025CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 11, 2025TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Sep 11, 2025CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 11, 2025TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 5, 2025XELGAPPLICATION EXTENSION GRANTED/RECEIPT PROVIDED—
Jun 5, 2025XELRAPPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED—
Mar 12, 2025GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 12, 2025GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 12, 2025CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 4, 2025DOCKASSIGNED TO EXAMINER—
Jan 17, 2025NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Aug 28, 2024NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance